MORE►
Novartis
Novartis breaks ground on its Denton radioligand therapy site. [Photo: Novartis]
Switzerland-Based Novartis Breaks Ground on Radioligand Therapy Site in Denton
by Sandra Engelland | May 12, 2026
When completed in 2028, the company’s first Texas‑based manufacturing facility will bring RLT medications closer to patients across the southern United States, becoming the fifth RLT site nationwide, Novartis said.
by Sandra Engelland |
Feb 25, 2026
The purpose-built radiopharmaceutical site is the company’s fifth in the U.S. and the first manufacturing facility in Texas. It's expected to create new jobs in bioengineering, advanced manufacturing, quality, and operations.
MORE►
by Sandra Engelland |
Jan 14, 2026
With more than two decades of experience in life sciences leadership, venture capital, and company building, Steven Weinstein brings a track record of guiding innovative healthcare organizations from early-stage development through commercialization, Carrollton-based Gradalis said.
MORE►
by Quincy Preston |
Sep 1, 2023
Tarleton State University received the go-ahead for a new biotechnology institute as part of Texas A&M-Fort Worth’s burgeoning downtown research campus.
Approved in mid-August by the Texas A&M University System Board of Regents, the biotech institute is situated in one of the nation’s fastest-growing life sciences hubs....
MORE►
[Image: via iStock/lisblu]
The (Alcon) Family Tree: How One Company Seeded a DFW Life Science Legacy
by Jeff Bounds | Jan 21, 2020
Alcon gave rise to a startup ecosystem in North Texas that is spreading into all parts of how drugs, medical devices, and more are created.
MORE►
by Lance Murray |
Mar 21, 2019
You’ll also find news about Mark Cuban, Fastsigns International, Blucora, 1st Global Inc., Alcon, and Signify Health in this roundup of funding and acquisition activity involving investors and companies with ties to North Texas.
MORE►
by Nicholas Sakelaris |
Jan 27, 2017
The Swiss pharmaceutical company paid $465 million for the Fort Worth eye care startup.
MORE►
by Lance Murray |
Dec 21, 2016
The company as developed a treatment for presbyopia, which can make it difficult for people to focus their eyes.
MORE►
